Sanofi and Regeneron's eczema drug gets FDA approval

The FDA approved Dupixent (dupilumab), is the first targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news